Products
CSL Behring Products
We develop and deliver innovative medicines for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angiodaema, among others.
UK Product Range
Take a look at the products we offer in the UK – including product information and prescribing information for each product.
Learn More
Adverse Event Reporting
Adverse events should be reported.
Reporting forms and information can be found at https://www.mhra.gov.uk/yellowcard. Adverse events should also be reported to CSL Behring UK Ltd. on 01444 447 405.
If you would like to contact CSL Behring for any other reason, please visit our Contact page to find the appropriate details.
GBR-CRP-0545 August 2024